Tissue Factor in the Pathogenesis of Atherosclerosis

Mark B Taubman; John T Fallon; Alison D Schecter; Peter Giesen; Milton Mendlowitz; Billie S Fyfe; Jonathan D Marmur; Yale Nemerson

doi:10.1055/s-0038-1657526

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1997; 78(01): 200-204
DOI: 10.1055/s-0038-1657526

Pathogenesis of atherosclerosis: a l997 update

Schattauer GmbH Stuttgart

Tissue Factor in the Pathogenesis of Atherosclerosis

Mark B Taubman

The Mount Sinai School of Medicine, New York, NY, USA

,

John T Fallon

The Mount Sinai School of Medicine, New York, NY, USA

,

Alison D Schecter

The Mount Sinai School of Medicine, New York, NY, USA

,

Peter Giesen

The Mount Sinai School of Medicine, New York, NY, USA

,

Milton Mendlowitz

The Mount Sinai School of Medicine, New York, NY, USA

,

Billie S Fyfe

The Mount Sinai School of Medicine, New York, NY, USA

,

Jonathan D Marmur

The Mount Sinai School of Medicine, New York, NY, USA

,

Yale Nemerson

The Mount Sinai School of Medicine, New York, NY, USA

› Institutsangaben

Abstract

als PDF herunterladen

PDF (1278 kb)

Referenzen

References
1 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-250
2 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 310-318
3 Losordo DW, Rosenfield K, Pieczek A, Baker K, Harding M, Isner JM. How does angioplasty work?: serial analysis of human iliac arteries using intravascular ultrasound. Circulation 1992; 86: 1845-1858
4 Nath FC, Muller DW, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman C, Topol EJ. Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. J Amer Col Card 1993; 21: 622-627
5 Carrozza Jr JP, Baim DS. Complications of directional coronary atherectomy: incidence, causes, and management. Am J Card 1993; 72: 47E-54E
6 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
7 Schwartz SM, Heimark RL, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev 1990; 70: 1177-1209
8 Huang CL, Ives HE. Growth inhibition by protein kinase C late in mitogenesis. Nature 1987; 329: 849-850
9 Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Nad Acad Sci, USA 1992; 89: 2317-2320
10 Ragosta M, Gimple LW, Haber HL, Dunwiddie CT, Vlasuk GP, Rowers ER, Sarembock IJ. Effectiveness of specific Factor Xa inhibition on restenosis following balloon angioplasty in rabbits. J Amer Col Cardiol 1992; 19: 164A
11 Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 01-08
12 Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66: 67-79
13 Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985; 53: 363-373
14 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Path 1989; 134: 1087-1097
15 Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Nad Acad Sci, USA 1989; 86: 2839-2843
16 Annex BH, Denning SM, Channon KM, Sketch Jr MH, Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-622
17 Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. The identification of active tissue factor in human coronary atheroma. Circulation. 1996
18 Moreno PR, Bemardi VH, Lopez-Cuellar J, Murcia AM, Palacios IF, Gold HK, Mehran R, Sharma SK, Nemerson Y, Fuster V, Fallon J. macrophages, smooth muscle cells, and tissue factor in unstable angina. Circulation 1996; 94: 3090-3097
19 Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin labeled factors Vila and X. Submitted, Lab Invest.
20 Badimon L, Badimon JJ, Galvez A, Chesebro J, Fuster V. Influence of arterial damage and wall shear rate on platelet deposition. Arteriosclerosis 1986; 06: 312-320
21 Mailhac A, Badimon JJ, Fallon JT, Femandez-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon L. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation 1994; 90: 988-996
22 Femandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol 1994; 23: 1562-1569
23 Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity. Thromb Haemost 1994; 71: 511-516
24 Maynard JR, Heckman CA, Pitlick FA, Nemerson Y. Association of tissue factor activity with the surface of cultured cells. J Clin Invest 1975; 55: 814-824
25 Steele PM, Chesebro JH, Stanson AW, Holmes D, Badimon L, Fuster V. Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-112
26 Stemerman MB. Thrombogenesis of the rabbit arterial plaque. An electron microscopic study. Am J Path 1973; 81: 15-42
27 Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. Lab Invest 1983; 49: 327-333
28 Richardson M, Kinlough-Rathbone RL, Groves HM, Jorgensen J, Mustard JF, Moore S. Ultrastructural changes in re-endothelialized and non-endothelialized rabbit aortic neo-intima following re-injury with a balloon catheter. Br J Exp Path 1984; 64: 597-611
29 Groves HM, Kinlough-Rathbone RL, Richardson M, Jorgensen J, Moore S, Mustard JF. Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival. Lab Invest 1982; 46: 605-612
30 Marmur JD, Rossikhina M, Guha A, Fyfe B, Friedrich V, Mendlowitz M, Nemerson Y, Taubman MB. Tissue factor is rapidly induced in arterial smooth muscle after balloon injury. J Clin Invest 1993; 91: 2253-2259
31 Pawashe AB, Golino P, Ambrosis G, Migliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsberg WK, Ezekowitz MD. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res 1994; 74: 56-63
32 Speidel CM, Eisenberg PR, Ruf W, Edgington TS, Abendschein DR. Tissue factor mediates prolonged procoagulant activity on the luminal surface of balloon-injured aortas in rabbits. Circulation 1995; 92: 3323-3330
33 Gallo R, Fallon JT, Toschi V, Gertz SD, Padurean A, Nemerson Y, Chesebro J, Fuster V, Badimon JJ. Bi-phasic increase of tissue factor activity after angioplasty in porcine coronary arteries. Circulation 1995; 92: 001-354
34 Jang IK, Gold HK, Leinbach RC, Fallon JT, Collen D, and Wilcox JN. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis. Arterioscler Thromb 1992; 12: 948-954
35 Jang Y, Guzman LA, Lincoff AM, Gottsauner-Wolf M, Forudi F, Hart CE, Courtman DW, Ezban M, Ellis SG, Topol EJ. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 1995; 92: 3041-3050
36 Holst J, Lindblad B, Bergqvist D, Nordfang O, Ostergaard PB, Petersen JG, Nielsen G, Hedner U. Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1- 161) in experimental venous thrombosis-a comparison with low molecular weight herpatin. Thromb Haemost 1994; 71: 214-219
37 Oltrana L, Speidel CM, Recchia D, Abendschein DR. Inhibition of tissue factor-mediated thrombosis markedly attenuates stenosis after balloon-induced arterial injury in hyperlipidemic minipigs. Circulation 1994; 90: 001-344
38 Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. J Biol Chem 1989; 264: 20705-20713
39 Crossman DC, Carr DP, Tuddenham EGD, Pearson JD, McVey JH. Regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782-9787
40 Nawroth PP, Stem DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163: 740-745
41 Conway EM, Bach R, Rosenberg RD, Konigsberg WH. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells. Thromb Res 1989; 53: 231-241
42 Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-130
43 Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone Jr MA. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160: 618-623
44 Brox JH, Osterud B, Bjrklid E, Fenton II JW. Production and availability of thromboplastin in endothelial cells: the effects of thrombin endotoxin and platelets. Br J Haematol 1984; 57: 239-246
45 Grabowski EF, Lam FP. Endothelial cell function, including tissue factor expression, under flow conditions. Thromb Haemost 1995; 74: 123-128
46 Mackman N. Regulation of the tissue factor gene. FASEB J 1995; 09: 883-889
47 Taubman MB, Marmur JD, Rosenfield CL, Guha A, Nichtberger S, Nemerson Y. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells: Role of Ca²⁺mobilization and protein kinase C activation. J Clin Invest 1993; 91: 547-552
48 Schecter AD, Fallon JT, Thiruvikraman SV, Taby O, Rosenfield CL, Rossikhina M, Nemerson Y, Taubman MB. Delayed surface expression of active tissue factor in human arterial smooth muscle cells determined by a novel in situ activity assay. Circulation 92: 01-804
49 Schecter AD, Fallon JT, Rossikhina M, Xhang X, Nemerson Y, Taubman MB. Monocyte chemoattractant protein 1 (MCP-1) induces tissue factor in human arterial smooth msucle cells (SMC) and monocytes. Blood 1995; 86: 286a
50 Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 5252-5256
51 Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991; 88: 1121-1127
52 Broze Jr GJ. Tissue factor pathway inhibitor. Thromb Haemost 1995; 74: 90-93
53 Waxman L, Smith DE, Arcuri KE, Vlasuk GP. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa, Science. 1990; 248: 593-596
54 Dunwiddie CT, Thornberry N, Bull H, Sardana M, Friedman P, Jacobs J, Simpson E. Antistasin, a leech-derived inhibitor of factor Xa: Kinetic analysis of enayme inhibition and identification of the reactive site. J Biol Chem 1989; 264: 16694-16699
55 Harlos K, Martin DM, O’Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EG, Boys CW. Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370: 662-666
56 Banner DW, D’Arcy A, Chene C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D. The crystal structure of the complex of blood coagulation factor Vila with soluble tissue factor. Nature 1996; 380: 41-46
57 Zeldis S, Nemerson Y, Pitlick R, Lentz T. Tissue factor (thromboplastin): localization by peroxidase conjugated antibodies. Science 1972; 175: 766-768